Diana I. Aparicio-Bautista

Dr. Diana I. Aparicio-Bautista

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
MBMarco Antonio Briones-Orta
Marco Antonio Briones-Orta
SAS. Eréndira Avendaño-Vázquez
S. Eréndira Avendaño-Vázquez
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
JCJason Coombes
Jason Coombes
GWGeorg F. Weber
Georg F. Weber
WSWING-KIN SYN
WING-KIN SYN

1 January 2009 in Free Radical Research
Verified
Journal Article
Closed access
VVVerónica Rocío Vásquez-Garzón
Verónica Rocío Vásquez-Garzón
JAJaime Arellanes-Robledo
Jaime Arellanes-Robledo
RGRebeca García-Román
Rebeca García-Román
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
STSaúl Villa Treviño
Saúl Villa Treviño
There is a correlation between oxidative stress generated by diethylnitrosamine (DEN) metabolism and liver cancer development. Quercetin is a flavonoid with anti-carcinogenic and antioxidant properties. This study demonstrates the mechanism of action for the chemopreventive effect of quercetin. A 10 mg/kg dose of quercetin produced drastic effect, when it is administrated 2 h before DEN; at 24 days post-DEN, a 70.3% and 66.2% decrease in total area and number of preneoplastic lesions were observed, respectively. At 12 h post-DEN, quercetin inhibited levels of lipid peroxidation by 40%. Quercetin increased the levels of both GSH and of total glutathione, it increased the GSH/GSSG index and it caused a rapid and simultaneous elevation in the activities of superoxide dismutase, glutathione peroxidase and catalase. In conclusion, the quercetin mechanism of action is due to promote the enzymatic and non-enzymatic antioxidant defense system during the initiation of hepatocarcinogenesis.

21 November 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
MMMayeli M. Martínez-Aguilar
Mayeli M. Martínez-Aguilar
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
EREric Ramirez-Salazar
Eric Ramirez-Salazar
JRJuan Pablo Reyes-Grajeda
Juan Pablo Reyes-Grajeda
Aldo H de la Cruz-MontoyaAldo H de la Cruz-Montoya
Aldo H de la Cruz-Montoya
RVRafael Velazquez-Cruz
Rafael Velazquez-Cruz
Osteoporosis is a skeletal disease mainly affecting women over 50 years old and it represents a serious public health problem because of the high socioeconomic burden. This disease is characterized by deterioration of bone microarchitecture, low bone mineral density (BMD), and increased risk of fragility fractures. This study aimed to identify serum useful proteins as biomarkers for the diagnosis and/or prognosis of osteoporosis and fracture risk. We collected 446 serum samples from postmenopausal women aged ≥45 years old. Based on the BMD measurement, we classified the participants into three groups: osteoporotic, osteopenic, and normal. In an initial discovery stage, we conducted a proteomic approach using two-dimensional differential gel electrophoresis (2D-DIGE). The peptides into the spots of interest were identified through matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF/TOF). Enzyme-linked immunosorbent assay (ELISA) was performed to validate the proteins of interest. We identified 27 spots of interest when comparing low BMD versus normal BMD postmenopausal women. Based on their relevance in bone metabolism, we analyzed three proteins: ceruloplasmin (CP), gelsolin (GSN), and vitamin D-binding protein (VDBP). Our results demonstrated that low serum VDBP levels correlate with low BMD (osteopenic and osteoporotic). Therefore, VDBP could be considered as a novel, potential, and non-invasive biomarker for the early detection of osteoporosis.

24 April 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
MJMónica Noemí Jiménez-García
Mónica Noemí Jiménez-García
JAJaime Arellanes-Robledo
Jaime Arellanes-Robledo
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
MRMiguel Ángel Rodríguez-Segura
Miguel Ángel Rodríguez-Segura
STSaúl Villa Treviño
Saúl Villa Treviño
JGJuan José Godina-Nava
Juan José Godina-Nava
Recently, extremely low frequency electromagnetic fields (ELF-EMF) have been studied with great interest due to their possible effects on human health. In this study, we evaluated the effect of 4.5 mT - 120 Hz ELF-EMF on the development of preneoplastic lesions in experimental hepatocarcinogenesis.

1 September 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
SFSergio Fuentes-Hernández
Sergio Fuentes-Hernández
BABrisa Rodope Alarcón-Sánchez
Brisa Rodope Alarcón-Sánchez
DGDafne Guerrero-Escalera
Dafne Guerrero-Escalera
AMAlexia Viridiana Montes-Aparicio
Alexia Viridiana Montes-Aparicio
MCMaría Paulette Castro-Gil
María Paulette Castro-Gil
JAJaime Arellanes-Robledo
Jaime Arellanes-Robledo

1 December 2013 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
DADiana I. Aparicio-Bautista
Diana I. Aparicio-Bautista
JPJulio Isael Perez-Carreon
Julio Isael Perez-Carreon
NGNora Gutiérrez-Nájera
Nora Gutiérrez-Nájera
JRJuan Pablo Reyes-Grajeda
Juan Pablo Reyes-Grajeda
JAJaime Arellanes-Robledo
Jaime Arellanes-Robledo
SVSaúl Villa-Treviño
Saúl Villa-Treviño